Invention Grant
US08715999B2 Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines
失效
在衣壳蛋白中含有缺失的黄病毒科突变体用作疫苗
- Patent Title: Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines
- Patent Title (中): 在衣壳蛋白中含有缺失的黄病毒科突变体用作疫苗
-
Application No.: US12866631Application Date: 2009-02-06
-
Publication No.: US08715999B2Publication Date: 2014-05-06
- Inventor: Franz X. Heinz , Christian Mandl , Petra Schlick , Andreas Meinke
- Applicant: Franz X. Heinz , Christian Mandl , Petra Schlick , Andreas Meinke
- Applicant Address: AT Vienna
- Assignee: Valneva Austria GmbH
- Current Assignee: Valneva Austria GmbH
- Current Assignee Address: AT Vienna
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: EP08101404 20080208
- International Application: PCT/EP2009/051351 WO 20090206
- International Announcement: WO2009/098277 WO 20090813
- Main IPC: C12N7/04
- IPC: C12N7/04 ; C12N15/86
Abstract:
The present invention relates to a mutant virus of the family flaviviridae, comprising a deletion in the capsid protein of at least 20 successive amino acids, without any further deletion, substitution or insertion mutation except of the amino acids next to the deletion, which may be substituted.
Public/Granted literature
- US20100323003A1 Flaviviridae Mutants Comprising a Deletion in the Capsid Protein for Use as Vaccines Public/Granted day:2010-12-23
Information query
